Dignitana AB (publ) (DIGN.ST)
SEK 0.92
(-2.65%)
SEK 0.92
(-2.65%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -15.02 Million SEK | 43.03% |
| 2022 | -30.04 Million SEK | 36.34% |
| 2021 | -47.19 Million SEK | 12.34% |
| 2020 | -53.84 Million SEK | -42.32% |
| 2019 | -37.83 Million SEK | -56.81% |
| 2018 | -24.12 Million SEK | 40.8% |
| 2017 | -40.75 Million SEK | -17.76% |
| 2016 | -34.6 Million SEK | -106.03% |
| 2015 | -16.79 Million SEK | -54.02% |
| 2014 | -10.9 Million SEK | 34.3% |
| 2013 | -16.59 Million SEK | -28.83% |
| 2012 | -12.88 Million SEK | -259.96% |
| 2011 | -3.57 Million SEK | 82.45% |
| 2010 | -20.39 Million SEK | -94.34% |
| 2009 | -10.49 Million SEK | -65.17% |
| 2008 | -6.35 Million SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -10.98 Million SEK | -119.66% |
| 2024 Q1 | -5 Million SEK | -22.76% |
| 2023 Q3 | -3.15 Million SEK | 32.27% |
| 2023 FY | -17.11 Million SEK | 43.03% |
| 2023 Q4 | -4.07 Million SEK | -29.14% |
| 2023 Q1 | -3.48 Million SEK | 82.87% |
| 2023 Q2 | -4.65 Million SEK | -33.55% |
| 2022 Q3 | -3.27 Million SEK | -1346.39% |
| 2022 Q4 | -20.35 Million SEK | -520.96% |
| 2022 FY | -30.04 Million SEK | 36.34% |
| 2022 Q1 | -6.14 Million SEK | 64.0% |
| 2022 Q2 | 263 Thousand SEK | 104.28% |
| 2021 Q1 | -7.13 Million SEK | 77.42% |
| 2021 Q3 | -13.59 Million SEK | -44.42% |
| 2021 Q4 | -17.05 Million SEK | -25.49% |
| 2021 FY | -47.19 Million SEK | 12.34% |
| 2021 Q2 | -9.41 Million SEK | -31.97% |
| 2020 FY | -53.84 Million SEK | -42.32% |
| 2020 Q1 | -8.76 Million SEK | 40.76% |
| 2020 Q3 | -5.28 Million SEK | 41.48% |
| 2020 Q4 | -31.58 Million SEK | -497.73% |
| 2020 Q2 | -9.02 Million SEK | -3.06% |
| 2019 Q2 | -7.1 Million SEK | -153.8% |
| 2019 Q1 | -2.79 Million SEK | 45.53% |
| 2019 Q3 | -9.92 Million SEK | -39.66% |
| 2019 Q4 | -14.78 Million SEK | -49.05% |
| 2019 FY | -37.83 Million SEK | -56.81% |
| 2018 Q3 | -5.43 Million SEK | -16.04% |
| 2018 Q1 | -8.78 Million SEK | 30.86% |
| 2018 Q2 | -4.68 Million SEK | 46.68% |
| 2018 Q4 | -5.13 Million SEK | 5.43% |
| 2018 FY | -24.12 Million SEK | 40.8% |
| 2017 FY | -40.75 Million SEK | -17.76% |
| 2017 Q4 | -12.7 Million SEK | -31.8% |
| 2017 Q3 | -9.64 Million SEK | 6.42% |
| 2017 Q2 | -10.3 Million SEK | -29.94% |
| 2017 Q1 | -7.92 Million SEK | 38.44% |
| 2016 Q4 | -12.87 Million SEK | -74.01% |
| 2016 Q3 | -7.4 Million SEK | 13.01% |
| 2016 FY | -34.6 Million SEK | -106.03% |
| 2016 Q1 | -5.81 Million SEK | -8.99% |
| 2016 Q2 | -8.5 Million SEK | -46.25% |
| 2015 Q4 | -5.33 Million SEK | -21.8% |
| 2015 FY | -16.79 Million SEK | -54.02% |
| 2015 Q3 | -4.38 Million SEK | -0.75% |
| 2015 Q2 | -4.34 Million SEK | -59.53% |
| 2015 Q1 | -2.72 Million SEK | -150.29% |
| 2014 Q2 | -2.46 Million SEK | 49.71% |
| 2014 Q1 | -4.9 Million SEK | -3.3% |
| 2014 FY | -10.9 Million SEK | 34.3% |
| 2014 Q4 | -1.08 Million SEK | 55.56% |
| 2014 Q3 | -2.45 Million SEK | 0.52% |
| 2013 Q2 | -4.48 Million SEK | -16.39% |
| 2013 Q1 | -3.85 Million SEK | 30.85% |
| 2013 Q3 | -3.51 Million SEK | 21.59% |
| 2013 Q4 | -4.74 Million SEK | -34.91% |
| 2013 FY | -16.59 Million SEK | -28.83% |
| 2012 FY | -12.88 Million SEK | -259.96% |
| 2012 Q1 | -1.43 Million SEK | 80.51% |
| 2012 Q3 | -2.95 Million SEK | 0.51% |
| 2012 Q4 | -5.57 Million SEK | -88.81% |
| 2012 Q2 | -2.96 Million SEK | -106.32% |
| 2011 Q1 | -3.15 Million SEK | 74.81% |
| 2011 Q2 | 6.03 Million SEK | 291.65% |
| 2011 FY | -3.57 Million SEK | 82.45% |
| 2011 Q4 | -7.37 Million SEK | -138.43% |
| 2011 Q3 | -3.09 Million SEK | -151.22% |
| 2010 Q1 | -2.42 Million SEK | 46.06% |
| 2010 Q2 | -3.54 Million SEK | -46.06% |
| 2010 Q4 | -12.5 Million SEK | -552.93% |
| 2010 Q3 | -1.91 Million SEK | 45.91% |
| 2010 FY | -20.39 Million SEK | -94.34% |
| 2009 Q4 | -4.49 Million SEK | -314.46% |
| 2009 Q2 | -2.97 Million SEK | -54.04% |
| 2009 FY | -10.49 Million SEK | -65.17% |
| 2009 Q1 | -1.93 Million SEK | 0.0% |
| 2009 Q3 | -1.08 Million SEK | 63.58% |
| 2008 FY | -6.35 Million SEK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acarix AB (publ) | -77.55 Million SEK | 80.625% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 104.999% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 104.999% |
| Arcoma AB | 4.66 Million SEK | 422.446% |
| Bactiguard Holding AB (publ) | -131.93 Million SEK | 88.611% |
| BICO Group AB (publ) | -618.3 Million SEK | 97.57% |
| Boule Diagnostics AB (publ) | 39.27 Million SEK | 138.263% |
| CellaVision AB (publ) | 167.05 Million SEK | 108.995% |
| Clinical Laserthermia Systems AB (publ) | -65.93 Million SEK | 77.21% |
| Chordate Medical Holding AB (publ) | -29.57 Million SEK | 49.188% |
| C-Rad AB (publ) | 44.24 Million SEK | 133.962% |
| Duearity AB (publ) | -25.76 Million SEK | 41.676% |
| Episurf Medical AB (publ) | -94.8 Million SEK | 84.15% |
| Getinge AB (publ) | 3.81 Billion SEK | 100.394% |
| Scandinavian Real Heart AB (Publ) | -68.44 Million SEK | 78.047% |
| Iconovo AB (publ) | -45.77 Million SEK | 67.175% |
| Integrum AB (publ) | 6.51 Million SEK | 330.731% |
| Luxbright AB (publ) | -25.8 Million SEK | 41.77% |
| Mentice AB (publ) | -679 Thousand SEK | -2112.96% |
| OssDsign AB (publ) | -91.95 Million SEK | 83.66% |
| Paxman AB (publ) | 12.61 Million SEK | 219.074% |
| Promimic AB (publ) | -9.11 Million SEK | -64.795% |
| Qlife Holding AB (publ) | -168.69 Million SEK | 91.093% |
| SciBase Holding AB (publ) | -53.93 Million SEK | 72.143% |
| ScandiDos AB (publ) | -13.48 Million SEK | -11.444% |
| Sectra AB (publ) | 518.49 Million SEK | 102.898% |
| Sedana Medical AB (publ) | -65.54 Million SEK | 77.076% |
| Senzime AB (publ) | -133.74 Million SEK | 88.765% |
| SpectraCure AB (publ) | -21.35 Million SEK | 29.624% |
| Stille AB | 44.95 Million SEK | 133.427% |
| Vitrolife AB (publ) | -3.58 Billion SEK | 99.581% |
| Xvivo Perfusion AB (publ) | 38.5 Million SEK | 139.022% |